Table 1. Correlation between GOLM1-MAK10 level and clinicopathologic variables in patients with ESCC.
| Variables | No. of patients | GOLM1-MAK10 | ||
|---|---|---|---|---|
| Low (%) | High (%) | P* | ||
| Total samples | 78 | 39 (50.0) | 39 (50.0) | |
| Sex | ||||
| Male | 60 | 31 (51.7) | 29 (48.3) | 0.591 |
| Female | 18 | 8 (44.4) | 10 (55.6) | |
| Age (years) | ||||
| ≤ 60 | 39 | 20 (51.3) | 19 (48.7) | 0.821 |
| > 60 | 39 | 19 (48.7) | 20 (51.3) | |
| Tumor location | ||||
| Upper/Middle | 68 | 35 (51.5) | 33 (48.5) | 0.498 |
| Lower | 10 | 4 (40.0) | 6 (60.0) | |
| Tumor size | ||||
| < 5 cm | 18 | 8 (44.4) | 10 (55.6) | 0.591 |
| ≥ 5 cm | 60 | 31 (51.7) | 29 (48.3) | |
| Histologic differentiation | ||||
| Well | 25 | 18 (72.0) | 7 (28.0) | 0.013 |
| Moderate | 35 | 16 (45.7) | 19 (54.3) | |
| Poor | 18 | 5 (27.8) | 13 (72.2) | |
| Tumor depth | ||||
| T1/T2 | 14 | 5 (35.7) | 9 (64.3) | 0.238 |
| T3/T4 | 64 | 34 (53.1) | 30 (46.9) | |
| Lymph node metastasis | ||||
| N0 | 38 | 24 (63.2) | 14 (36.8) | 0.023 |
| N1 | 40 | 15 (37.5) | 25 (62.5) | |
| Stage | ||||
| I/II | 42 | 21 (50.0) | 21 (50.0) | 1.000 |
| III | 36 | 18 (50.0) | 18 (50.0) | |
*
As determined by chi-square test